相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A platinum@polymer-catechol nanobraker enables radio-immunotherapy for crippling melanoma tumorigenesis, angiogenesis, and radioresistance
Wenxi Li et al.
BIOACTIVE MATERIALS (2023)
Secretions from hypochlorous acid-treated tumor cells delivered in a melittin hydrogel potentiate cancer immunotherapy
Yuhan Zhou et al.
BIOACTIVE MATERIALS (2022)
Delivery Strategies for Melittin-Based Cancer Therapy
Jie Zhou et al.
ACS APPLIED MATERIALS & INTERFACES (2021)
CpG Oligodeoxynucleotides Induces Apoptosis of Human Bladder Cancer Cells via Caspase-3-Bax/Bcl-2-p53 Axis
Yang Luo et al.
ARCHIVES OF MEDICAL RESEARCH (2020)
Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel
Xiaomeng Dai et al.
THERANOSTICS (2020)
Current state of melanoma diagnosis and treatment
Lauren E. Davis et al.
CANCER BIOLOGY & THERAPY (2019)
Moving treatments earlier to move further forwards
Michael A. Davies et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Tumor Ablation and Therapeutic Immunity Induction by an Injectable Peptide Hydrogel
Honglin Jin et al.
ACS NANO (2018)
Injectable polypeptide hydrogel for dual-delivery of antigen and TLR3 agonist to modulate dendritic cells in vivo and enhance potent cytotoxic T-lymphocyte response against melanoma
Huijuan Song et al.
BIOMATERIALS (2018)
Cancer vaccines: translation from mice to human clinical trials
Hoyoung Maeng et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Correlates of immune and clinical activity of novel cancer vaccines
Sjoerd H. van der Burg
SEMINARS IN IMMUNOLOGY (2018)
Biomaterials for vaccine-based cancer immunotherapy
Rui Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Towards personalized, tumour-specific, therapeutic vaccines for cancer
Zhuting Hu et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Targeted agents and immunotherapies: optimizing outcomes in melanoma
Jason J. Luke et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine
Gao-Na Shi et al.
BIOMATERIALS (2017)
Melittin-Containing Hybrid Peptide Hydrogels for Enhanced Photothermal Therapy of Glioblastoma
Honglin Jin et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Self-assembling peptide-based building blocks in medical applications
Handan Acar et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Beyond antigens and adjuvants: formulating future vaccines
Tyson J. Moyer et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Self-assembled peptide nanostructures for functional materials
Melis Sardan Ekiz et al.
NANOTECHNOLOGY (2016)
Immunotherapy of melanoma: Present options and future promises
Anand Rotte et al.
CANCER AND METASTASIS REVIEWS (2015)
A tumor lysate is an effective vaccine antigen for the stimulation of CD4+ T-cell function and subsequent induction of antitumor immunity mediated by CD8+ T cells
Mamoru Kawahara et al.
CANCER BIOLOGY & THERAPY (2015)
CpG oligodeoxynucleotides as mucosal adjuvants
Sumiko Iho et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Melanoma
Dirk Schadendorf et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment
Laura J. Vella et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2014)
The Tipping Point for Combination Therapy: Cancer Vaccines With Radiation, Chemotherapy, or Targeted Small Molecule Inhibitors
James W. Hodge et al.
SEMINARS IN ONCOLOGY (2012)
Improvement of different vaccine delivery systems for cancer therapy
Azam Bolhassani et al.
MOLECULAR CANCER (2011)
Slow and sustained release of active cytokines from self-assembling peptide scaffolds
Fabrizio Gelain et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
Joerg Vollmer et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors
Abdeljabar El Andaloussi et al.
GLIA (2006)
Immunotherapeutic uses of CpG oligodeoxynucleotides
DM Klinman
NATURE REVIEWS IMMUNOLOGY (2004)